Descargar el archivo PDF

Re vista
ARTÍCULO ORIGINAL
Rev Alerg Méx HIYQ\U"!
Mé xic o
Repercusión de la inmunoterapia
con alergenos luego de dos años de
suspensión a pacientes con asma
Jorge Sánchez,1,2 Ricardo Cardona,1 Andrés Sánchez3
Resumen
(5;,*,+,5;,:! la PUT\UV[LYHWPHOHKLTVZ[YHKVZ\LÄJHJPHLULSJVU[YVS
KLSHZTHHStYNPJH"ZPULTIHYNVWVJVZLZ[\KPVZOHUL]HS\HKVZPLSJVU[YVS
`SHYLK\JJP}UKLS[YH[HTPLU[VMHYTHJVS}NPJVWLYZPZ[LUHSZ\ZWLUKLYSV
6)1,;0=6!L]HS\HYLSLMLJ[VKLSHPUT\UV[LYHWPHJVUmJHYVZLUWHJPLU[LZJVUHZTHS\LNVKLKVZH|VZKLZ\ZWLUZP}U
4i;6+6:!LZ[\KPVHTIPZWLJ[P]VVIZLY]HJPVUHSHIPLY[VJVUNY\WVHJ[P]V
PUT\UV[LYHWPH`MHYTHJV[LYHWPH`NY\WVJVU[YVSMHYTHJV[LYHWPHJVUZLN\PTPLU[VK\YHU[LJPUJVH|VZ!KP]PKPKVLUKVZMHZLZ![YLZH|VZKLHWSPJHJP}U
KLSHPUT\UV[LYHWPH`KVZH|VZKLZLN\PTPLU[VS\LNVKLZ\Z\ZWLUZP}U
9,:<3;(+6:!ZLPUJS\`LYVU WHJPLU[LZLULSNY\WVHJ[P]V`LULS
NY\WVJVU[YVS(TIVZNY\WVZ[\]PLYVUTLUVYU‚TLYVKLL_HJLYIHJPVULZS\LNV
KLSZL_[VTLZp$+LZW\tZKLU\L]LTLZLZLSNY\WVHJ[P]V[\]V\UH
YLK\JJP}UPTWVY[HU[LLUSHULJLZPKHKKLHWSPJHJP}UKLLZ[LYVPKLZPUOHSHKVZ
(p$versusLSNY\WVJVU[YVS+LZW\tZKLKVZH|VZKLSHZ\ZWLUZP}UKLSH
PUT\UV[LYHWPHSHKVZPZKLPUOHSHKVYLZX\LYLJPIxHUSVZWHJPLU[LZLULSNY\WV
HJ[P]VM\LTLUVYX\LSHKLSNY\WVJVU[YVS3VZTLUVYLZKLH|VZTVUVZLUZPIPSPaHKVZ[\]PLYVUSHTLQVYYLZW\LZ[HLU[VKVZSVZWHYmTL[YVZL]HS\HKVZ
*65*3<:0Ô5! SHPUT\UV[LYHWPHJVUHSLYNLUVZKPZTPU\`LSVZZxU[VTHZKLS
HZTH`SHZKVZPZKLTLKPJHTLU[VZULJLZHYPHZWHYHLSJVU[YVSKLSWHJPLU[L
,Z[VZLMLJ[VZ[PLULU\UHYLWLYJ\ZP}UZPNUPÄJH[P]HLUSHJHSPKHKKL]PKH`LU
SHLJVUVTxHKLSVZWHJPLU[LZJVUHZTH,SPUPJPVHLKHKLZ[LTWYHUHZWHYLJL
[LULYTH`VYPTWHJ[VJSxUPJV
7(3()9(:*3(=,!HSLYNPHHZTHmJHYVZHStYNLUVZDermatophagoides)SVTPHLÄJHJPHJVZ[VLJVUVTxHPUT\UV[LYHWPHZLUZPIPSPaHJP}U
1
9L](SLYN4t_(WY1\U"!
ITWHJ[VMHSSLYNLUPTT\UV[OLYHW`HM[LY
[^V`LHYZVMZ\ZWLUZPVUPUWH[PLU[Z^P[O
asthma
Jorge Sánchez,1,2 Ricardo Cardona,1 Andrés Sánchez3
Abstract
)(*2.96<5+! 0TT\UV[OLYHW`OHZWYV]LU[VILLMMLJ[P]LPUJVU[YVSSPUNHSSLYNPJHZ[OTH/V^L]LYML^Z[\KPLZOH]LL]HS\H[LK^OL[OLY[OL
JVU[YVSHUKYLK\J[PVUVMKY\N[YLH[TLU[WLYZPZ[HM[LY[YLH[TLU[LUKZ
www.nietoeditores.com.mx
'ƌƵƉŽ ĚĞ ůĞƌŐŝĂ ůşŶŝĐĂ LJ džƉĞƌŝŵĞŶƚĂů͘ /W^
hŶŝǀĞƌƐŝƚĂƌŝĂ͕ hŶŝǀĞƌƐŝĚĂĚ ĚĞ ŶƟŽƋƵŝĂ͕ DĞĚĞůůşŶ͕
ŶƟŽƋƵŝĂ͕ŽůŽŵďŝĂ͘
2
&ƵŶĚĂĐŝſŶƉĂƌĂĞůĞƐĂƌƌŽůůŽĚĞůĂƐŝĞŶĐŝĂƐDĠĚŝĐĂƐ
LJŝŽůſŐŝĐĂƐ͕ĂƌƚĂŐĞŶĂ͕ŽůŽŵďŝĂ͘
3
ŽƌƉŽƌĂĐŝſŶhŶŝǀĞƌƐŝƚĂƌŝĂZĂĨĂĞůEƷŹĞnj͘WƌŽŐƌĂŵĂ
ĚĞDĞĚŝĐŝŶĂ͕ĂƌƚĂŐĞŶĂ͕ŽůŽŵďŝĂ͘
Recibido: 20 de junio 2015
Aceptado: 22 de octubre 2015
Correspondencia
Jorge Sánchez
[email protected]
ƐƚĞĂƌơĐƵůŽĚĞďĞĐŝƚĂƌƐĞĐŽŵŽ
Sánchez J, Cardona R, Sánchez A. Repercusión de la
inmunoterapia con alergenos luego de dos años de
suspensión a pacientes con asma. Rev Alerg Méx.
ϮϬϭϲĂďƌͲũƵŶ͖ϲϯ;ϮͿ͗ϭϭϯͲϭϮϮ͘
113
2016 abril-junio;63(2)
Revista Alergia México
6)1,*;0=,! ;V L]HS\H[L [OL LMMLJ[ VM PTT\UV[OLYHW` ^P[O TP[LZ PU
HZ[OTHWH[PLU[ZHM[LY[^V`LHYZVMP[ZZ\ZWLUZPVUVUKY\N[YLH[TLU[HUK
U\TILYVML_HJLYIH[PVUZ
4(;,90(3 (5+ 4,;/6+! 6IZLY]H[PVUHS Z[\K` HTIPZWLJ[P]L ^P[O
HJ[P]LNYV\WPTT\UV[OLYHW`HUKWOHYTHJV[OLYHW`HUKJVU[YVSVUS`
WOHYTHJV[OLYHW`NYV\WMVSSV^LK\WMVY`LHYZKP]PKLKPU[V[^VWOHZLZ!
`LHYZ VM HWWSPJH[PVU VM PTT\UV[OLYHW` HUK [^V `LHY VM MVSSV^\W
HM[LYP[ZZ\ZWLUZPVU
9,:<3;:! WH[PLU[ZPU[OLHJ[P]LNYV\WHUKPU[OLJVU[YVSNYV\W
^LYL PUJS\KLK )V[O NYV\WZ OHK ML^LY L_HJLYIH[PVUZ HM[LY [OL ZP_[O
TVU[OW$(M[LYUPULTVU[OZ[OLHJ[P]LNYV\WOHKHZPNUPÄJHU[
YLK\J[PVU PU [OL \ZL VM PUOHSLK Z[LYVPKZ W $ JVTWHYLK [V [OL
JVU[YVSNYV\W;^V`LHYZHM[LYÄUPZOLKPTT\UV[OLYHW`WH[PLU[ZPU[OL
HJ[P]L NYV\W YLJLP]LK H SV^LY PUOHSLY KVZLZ [OHU [OL JVU[YVS NYV\W
*OPSKYLU\UKLY`LHYZTVUVZLUZP[PaLKOHK[OLILZ[YLZWVUZLPUHSS
WHYHTL[LYZL]HS\H[LK
*65*3<:065!;OLHSSLYNLUPTT\UV[OLYHW`PTWYV]LZHZ[OTHJVU[YVS
HUKYLK\JLZ[OLYLX\PYLKKVZLZVMWOHYTHJV[OLYHW`;OLZLLMMLJ[ZOH]L
HUPTWVY[HU[PTWHJ[VUX\HSP[`VMSPMLHUKWLYOHWZLJVUVTPJHSS`MVY
WH[PLU[Z^P[OHZ[OTH;OLILNPUUPUNH[HULHYS`HNLZLLTZ[VOH]LH
major impact.
2,@>69+:! (SSLYN`(Z[OTH4P[LZ(SSLYNLUBlomia, Dermatophagoides,,MÄJHJ`*VZ[,JVUVT`0TT\UV[OLYHW`:LUZP[PaH[PVU
ANTECEDENTES
,SHZTHLZ\UHLUMLYTLKHKMYLJ\LU[LLU3H[PUVHTtYPJH`LUSHWVISHJP}UT\UKPHS En 60 a
KLSVZJHZVZL_PZ[L\UJVTWVULU[LH[}WPJV
LUZ\ÄZPVWH[VSVNxHJVU\UHV]HYPHZM\LU[LZKL
HStYNLUVZJVTVJH\ZHKLSVZZxU[VTHZ *HZP
ZPLTWYLZLPUPJPHK\YHU[LSHWYPTLYHKtJHKHKL
SH ]PKH ` H\UX\L LU \U NY\WV PTWVY[HU[L KL
WHJPLU[LZZ\LSLYLTP[PYK\YHU[LSHHKVSLZJLUJPH
T\JOVZ JVU[PU‚HU JVU SVZ ZxU[VTHZ ` [PLUKL
H LTWLVYHY JVU LS [YHUZJ\YYPY KL SVZ H|VZ 10
(J[\HSTLU[L SVZ TLKPJHTLU[VZ JVU[YVSHKVYLZ
JVTV SVZ LZ[LYVPKLZ ` SVZ IL[HHNVUPZ[HZ ZVU
SH WPLKYH HUN\SHY KLS [YH[HTPLU[V ZPU[VTm[PJV
KLS HZTH WLYV UV KL[PLULU SH WYVNYLZP}U KL
U\L]HZ ZLUZPIPSPaHJPVULZ ` [PLULU LS YPLZNV KL
WYVK\JPYLMLJ[VZHK]LYZVZJVUZ\\ZVJVU[PU\V
3HPUT\UV[LYHWPHJVUHStYNLUVZOHKLTVZ[YHKV
Z\LÄJHJPHLULS[YH[HTPLU[VKLSHZLUMLYTLKHKLZ
114
1
'ƌƵƉŽĚĞůĞƌŐŝĂůşŶŝĐĂLJdžƉĞƌŝŵĞŶƚĂů͘
/W^hŶŝǀĞƌƐŝƚĂƌŝĂ͕hŶŝǀĞƌƐŝĚĂĚĚĞŶƟŽƋƵŝĂ͕
DĞĚĞůůşŶ͕ŶƟŽƋƵŝĂ͕ŽůŽŵďŝĂ͘
2
&ƵŶĚĂĐŝſŶ ƉĂƌĂ Ğů ĞƐĂƌƌŽůůŽ ĚĞ ůĂƐ
ŝĞŶĐŝĂƐ DĠĚŝĐĂƐ LJ ŝŽůſŐŝĐĂƐ͕ ĂƌƚĂŐĞŶĂ͕
ŽůŽŵďŝĂ͘
3
ŽƌƉŽƌĂĐŝſŶ hŶŝǀĞƌƐŝƚĂƌŝĂ ZĂĨĂĞů EƷŹĞnj͘
WƌŽŐƌĂŵĂ ĚĞ DĞĚŝĐŝŶĂ͕ ĂƌƚĂŐĞŶĂ͕ ŽůŽŵďŝĂ͘
Correspondence
Jorge Sánchez
[email protected]
YLZWPYH[VYPHZHStYNPJHZ11,12W\KPLUKVJVU[YVSHYSVZ
ZxU[VTHZ`YLK\JPYSHULJLZPKHKKLTLKPJHTLU[VZWVYTLKPVKLSHPUK\JJP}UKL\UH[VSLYHUJPH
PUT\UVS}NPJHHSVZHStYNLUVZX\LYLHJJPVUHLS
paciente.+LIPKVHSYPLZNVKLYLHJJPVULZ
K\YHU[L Z\ HKTPUPZ[YHJP}U LZ ULJLZHYPV X\L LS
WHJPLU[LJVUHZTH[LUNH\UJVU[YVSZPU[VTm[PJV
WHYHL]P[HYYLHJJPVULZZL]LYHZTPLU[YHZZLJVUZPN\LZ\PUT\UVTVK\SHJP}U16*VULS[YHUZJ\YYPY
KLS[PLTWVLSWHJPLU[LJVUZPN\L\UTLQVYJVU[YVS
ZPU[VTm[PJV`W\LKL[VSLYHYSHZ\ZWLUZP}UWHYJPHS V [V[HS KLS [YH[HTPLU[V MHYTHJVS}NPJV
(SN\UVZ LZ[\KPVZ Z\NPLYLU X\L LS LMLJ[V KL SH
PUT\UV[LYHWPH W\LKL WLYK\YHY K\YHU[L ]HYPVZ
H|VZS\LNVKLZ\Z\ZWLUZP}UZPZLOHJLLSJPJSV
JVTWSL[V H H|VZ" ZPU LTIHYNV SH TH`VY
WHY[LKLLZVZLZ[\KPVZZLLMLJ[\HYVULUWHJPLU[LZ
ZLUZPIPSPaHKVZHNYHUVZKLWVSLUJVUYPUP[PZ20,21
` WVJV ZL ZHIL ZP LZ[L LMLJ[V ZL YLWYVK\JL LU
WHJPLU[LZ ZLUZPIPSPaHKVZ H mJHYVZ WYPUJPWHS
Re vista
Sánchez J y col. Impacto de la inmunoterapia con alergenos después de su suspensión
M\LU[LKLHSLYNLUVZLULS[Y}WPJV`JVUZxU[VTHZ
YLZWPYH[VYPVZTmZZL]LYVZJVTVLSHZTH
,ULZ[LHY[xJ\SVZLL]HS‚HJVTVKLZLUSHJLWYPTHYPVLSLMLJ[VJSxUPJVKLSHPUT\UV[LYHWPHLU
WHJPLU[LZJVUHZTHZLUZPIPSPaHKVZHmJHYVZKVZ
H|VZKLZW\tZKLOHILY[LYTPUHKVLS[YH[HTPLU[V
3HZ]HYPHISLZ\[PSPaHKHZM\LYVU!TLKPJP}UKLSU‚TLYVKLL_HJLYIHJPVULZ`SHKVZPZKL[YH[HTPLU[V
MHYTHJVS}NPJV*VTVKLZLUSHJLZZLJ\UKHYPVZZL
L]HS\}ZPSHLKHKKLPUPJPVHSHPUT\UV[LYHWPH
LZ\UMHJ[VYX\LPUÅ\`LLUSHL]VS\JP}UJSxUPJH
MATERIAL Y MÉTODO
,Z[\KPVSVUNP[\KPUHSHTIPZWLJ[P]VHIPLY[VUV
PU[LY]LUJPVUPZ[HJVUMVYTHKVWVY\UHJVOVY[LKL
WHJPLU[LZJVUKPHNU}Z[PJVKLHZTHX\LHZPZ[PLYVUKLZLW[PLTIYLKL HLULYVKLHS
JLU[YVKLZHS\KKLSH<UP]LYZPKHKKL(U[PVX\PH
4LKLSSxU*VSVTIPH (WHY[PYKLLZ[HWVISHJP}U
ZLMVYTHYVUKVZNY\WVZZLN‚UZPYLJPIPLYVUZVSV
[YH[HTPLU[VJVUMmYTHJVZJVU[YVSVHKLTmZ
PUT\UV[LYHWPHZ\IJ\[mULHJVUmJHYVZ+LYM+LY
W`V)SV[HJ[P]V,SLZX\LTHKLPUT\UV[LYHWPH
\[PSPaHKV M\L ¸\S[YHY\ZO¹ JVU \UH KVZPZ Z\IJ\[mULHKLTSKLTHU[LUPTPLU[VTLUZ\HS
+LIPKVHX\LLZ[LLZ[\KPVM\LUVPU[LY]LUJPVUPZ[HSHHKTPUPZ[YHJP}UVUVKLPUT\UV[LYHWPHZL
KL[LYTPU}ZLN‚ULSJYP[LYPVTtKPJVVSHWYLMLYLUJPHKLSWHJPLU[LK\YHU[LSHJVUZ\S[HPUPJPHS7HYH
YLK\JPYSVZZLZNVZHSTVTLU[VKLSHZLSLJJP}U
WVY JHKH WHJPLU[L X\L M\L HKTP[PKV HS NY\WV
KLPUT\UV[LYHWPHZLPUJS\`LYVUHSTLUVZKVZ
WHJPLU[LZ HS NY\WV JVU[YVS JVU JHYHJ[LYxZ[PJHZ
ZPTPSHYLZ ZVJPVKLTVNYmÄJHZ ` HZVJPHKHZ JVU
SH LUMLYTLKHK [PLTWV KL PUPJPV ZL]LYPKHK
[YH[HTPLU[VL[J
7HYH SH L]HS\HJP}U KLS KLZLUSHJL WYPTHYPV
JVTV]HYPHISLZKLTLKPJP}UZL\Z}LSU‚TLYV
KLL_HJLYIHJPVULZ`LS[YH[HTPLU[VMHYTHJVS}NPJVLUYLSHJP}UJVUSHKVZPZKxH7HYHL]HS\HY
LSKLZLUSHJLZLJ\UKHYPVZLLMLJ[\}\UHUmSPZPZ
Mé xic o
LZ[YH[PÄJHKV KL HJ\LYKV JVU SH LKHK KL SVZ
WHJPLU[LZ TLUVYLZ V TH`VYLZ KL H|VZ
:L LZJVNP} SH LKHK KL H|VZ [LUPLUKV LU
J\LU[HSVZYLZ\S[HKVZVIZLY]HKVZLULZ[\KPVZ
WYL]PVZLUSHWVISHJP}UKLLZ[\KPV22;VKVZSVZ
WHJPLU[LZYLJPIPLYVU[YH[HTPLU[VMHYTHJVS}NPJVKLHJ\LYKVJVUSHZYLJVTLUKHJPVULZKLSHZ
N\xHZ.05(^^^NPUHZ[OTHVYNJVULZ[LYVPKLZ HU[PSL\JV[YPLUVZ V IL[HHNVUPZ[HZ ZLN‚U
SHZL]LYPKHKSHWYVNYLZP}U`LSJVU[YVSKLSVZ
ZxU[VTHZ+LIPKVHSHZKPMLYLUJPHZLUSHZKVZPZ
KLLZ[LYVPKLZ`LULS[YH[HTPLU[VZLN‚USHLKHK
KLSVZWHJPLU[LZZLOPaV\UHJVTWHYHJP}ULU[YLSVZNY\WVZKLLKHKZLN‚ULSWVYJLU[HQLKL
JHTIPVKLSHKVZPZLUYLSHJP}UJVULS[PLTWV
KL HKTPUPZ[YHJP}U +LIPKV H X\L LS LZ[\KPV
UV M\L PU[LY]LUJPVUPZ[H ` HSN\UVZ KH[VZ LYHU
YL[YVZWLJ[P]VZ SH ZL]LYPKHK KL SHZ L_HJLYIHJPVULZ UV W\KV TLKPYZL :VSV ZL PUJS\`LYVU
SHZX\LYLWVY[HYVU\ZVKLZHSI\[HTVSJVULZX\LTHKLYLZJH[LVSHHZPZ[LUJPHH\YNLUJPHZV
HTIHZ,SHWLNVHS[YH[HTPLU[VMHYTHJVS}NPJV
`Z\ZKVZPZ[HTIPtUM\LYLNPZ[YHKV
Criterios de selección
:L PUJS\`LYVU WHJPLU[LZ TH`VYLZ KL [YLZ H|VZ
KLLKHKJVUHZTHHStYNPJHWLYZPZ[LU[LKLZL]LYPKHK TVKLYHKH ` ZLUZPIPSPaHJP}U KLTVZ[YHKH
HmJHYVZDermatophagoides farinae +LYM+
pteronyssinus +LYWVBlomia tropicalis )SV[
J\`VZZxU[VTHZYLZWPYH[VYPVZO\IPLYHUPUPJPHKV
K\YHU[LSHWYPTLYHKtJHKHKLSH]PKH:LL_JS\`LYVUSVZWHJPLU[LZKLSNY\WVJVU[YVS`HJ[P]V
X\LYLX\PYPLYHULS\ZVWLYTHULU[LKLPUT\UVZ\WYLZVYLZ V X\L [\]PLYHU JVU[YHPUKPJHJP}U H
SVZTLKPJHTLU[VZJVU]LUJPVUHSLZWHYHJVU[YVS
KLSHZTHVSHPUT\UV[LYHWPH23;HTWVJVZLPUJS\`LYVUHSLZ[\KPVSVZWHJPLU[LZX\LO\IPLYHU
YLJPIPKV WYL]PHTLU[L HSN‚U HNLU[L IPVS}NPJV
3VZWHJPLU[LZJVUPUT\UV[LYHWPHKLIxHUOHILY
[LUPKV \U J\TWSPTPLU[V HU\HS HS [YH[HTPLU[V
KLHSTLUVZLUJ\HU[VHSU‚TLYVKLKVZPZ
HKTPUPZ[YHKHZ
115
2016 abril-junio;63(2)
Revista Alergia México
;VKVZ SVZ WHJPLU[LZ [LUxHU L]HS\HJP}U KL SH
ZLUZPIPSPaHJP}UHSHZM\LU[LZKLHStYNLUVZTmZ
MYLJ\LU[LZLUSHWVISHJP}UKLLZ[\KPVTLKPHU[L
WY\LIHZ PU[YHLWPKtYTPJHZ V TLKPJP}U KL 0N,
LZWLJxÄJHKLHJ\LYKVJVUSVZJYP[LYPVZKLS.(3,5
Consideraciones éticas
,S [YH[HTPLU[V MHYTHJVS}NPJV V PUT\UV[LYHWPH
HKTPUPZ[YHKV H [VKVZ SVZ WHJPLU[LZ ZPN\P} SVZ
SPULHTPLU[VZKLSHZN\xHZPU[LYUHJPVUHSLZKL[YH[HTPLU[VJVU]LUJPVUHSKLSHZTH3VZKH[VZX\L
ZLYLWVY[HUZVUYLZ\S[HKVKLSZLN\PTPLU[VKLSVZ
WHJPLU[LZ`SHYL]PZP}UZPZ[LTm[PJHKLZ\ZYLNPZ[YVZ
JSxUPJVZ;VKVZSVZWHJPLU[LZVLUJHZVKLZLY
TLUVYLZKLLKHKZ\ZWHKYLZV[\[VYLZÄYTHYVU
\UJVUZLU[PTPLU[VPUMVYTHKVWHYHLSPUPJPVKL
SHPUT\UV[LYHWPH]HSPKHKVWVYLSJVTP[tKLt[PJH
KL SH <UP]LYZPKHK KL (U[PVX\PH X\L HKLTmZ
L]HS\}`V[VYN}LSWLYTPZVWHYHSHL]HS\HJP}U
KLSVZYLNPZ[YVZYLZWL[HUKVLSHUVUPTH[VKLSVZ
pacientes.
Análisis
3VZ HUmSPZPZ ZL YLHSPaHYVU JVU LS WYVNYHTH KL
J}TW\[V :7:: ]LYZP}U WHYH >PUKV^Z JVU
<KL>PSJV_VUWHYHHUmSPZPZPU[LYNY\WVZ4HUU
>OP[UL` WHYH PU[YHNY\WVZ ` SH WY\LIH; WHYH
KPMLYLUJPHZKLTLKPHLUT\LZ[YHZPUKLWLUKPLU[LZ<UHp#ZLJVUZPKLY}LZ[HKxZ[PJHTLU[L
ZPNUPÄJH[P]H+LIPKVHX\LLSLMLJ[VKLSHPUT\UV[LYHWPHLZKL[LJ[HISLKLZW\tZKL]HYPVZTLZLZ
KLZ\HWSPJHJP}USVZHUmSPZPZZLLMLJ[\HYVUJVU
IHZLLUHUmSPZPZWVYWYV[VJVSV7HYHLSHUmSPZPZ
KLT‚S[PWSLZJVTWHYHJPVULZZL\[PSPa}LS[LZ[KL
+\UU3HZWYVWVYJPVULZZLHUHSPaHYVUJVU[HISHZ
KLJVU[PUNLUJPHZ`WY\LIHL_HJ[HKL-PZOLY
RESULTADOS
+\YHU[LLSWLYPVKVKLL]HS\HJP}UZLYL]PZHYVU
OPZ[VYPHZJSxUPJHZ,ULSNY\WVJVU[YVS
116
WHJPLU[LZ`LULSNY\WVHJ[P]VJ\TWSPLYVU
JVU SVZ JYP[LYPVZ KL PUJS\ZP}U ` LS WLYPVKV KL
L]HS\HJP}U,SWYPUJPWHSTV[P]VKLUVPUJS\ZP}U
HSLZ[\KPVKL\UWHJPLU[LM\LSHMHS[HKLKH[VZ
LU SH OPZ[VYPH JSxUPJH YLZWLJ[V KL SHZ ]HYPHISLZ
KLLZ[\KPVU‚TLYVKLL_HJLYIHJPVULZKVZPÄJHJP}UKLS[YH[HTPLU[VMHYTHJVS}NPJVTV[P]VZ
KLZ\ZWLUZP}UKLS[YH[HTPLU[VL[J-PN\YH
3HZ JHYHJ[LYxZ[PJHZ KL SVZ WHJPLU[LZ L_JS\PKVZ
M\LYVUZPTPSHYLZHSHZKLSVZWHJPLU[LZX\LWLYTHULJPLYVU K\YHU[L LS ZLN\PTPLU[V 3H LKHK
KLSVZWHJPLU[LZZL]LYPKHKKLSVZZxU[VTHZSH
LKHKTLKPHHSPUPJPVKLSHZTH`LS[YH[HTPLU[V
MHYTHJVS}NPJVM\LYVUZPTPSHYLZLUHTIVZNY\WVZ
;VKVZ SVZ WHJPLU[LZ LZ[HIHU ZLUZPIPSPaHKVZ H
mJHYVZ)SV[+LYM`V+LYW`SHMYLJ\LUJPHKL
ZLUZPIPSPaHJP}UHTHZJV[HZM\LZ\WLYPVYHS
*\HKYV
Evaluación del control de síntomas
,U SH WYPTLYH L]HS\HJP}U [VKVZ SVZ WHJPLU[LZ
OHIxHU [LUPKV \UH V TmZ L_HJLYIHJPVULZ KL
HZTHHSTLZ,USH-PN\YHZLYLWYLZLU[HLS[V[HS
KLL_HJLYIHJPVULZWVYH|VLUJHKHNY\WV,U
WYVTLKPV HS PUPJPHY LS LZ[\KPV JHKH WHJPLU[L
Registros excluidos por
falta de información
completa: n= 508
Registros revisados
n= 1014
Grupo activo
n= 122
Grupo control
n= 384
Evaluación exacerbaciones,
farmacoterapia e inmunoterapia
Evaluación exacerbaciones,
y famacoterapia
-PN\YH,UHTIVZNY\WVZZLL]HS\}SHZL]LYPKHK`
MYLJ\LUJPHKLSHZL_HJLYIHJPVULZHSPN\HSX\LSHKVZPZ
KL SVZ MmYTHJVZ ` SVZ WVZPISLZ LMLJ[VZ HK]LYZVZ KLS
[YH[HTPLU[V ,S [PLTWV KL L]HS\HJP}U M\L KL JPUJV
H|VZ ,S NY\WV HJ[P]V YLJPIP} PUT\UV[LYHWPH LU SVZ
primeros tres años.
Re vista
Sánchez J y col. Impacto de la inmunoterapia con alergenos después de su suspensión
*\HKYV*HYHJ[LYxZ[PJHZKLSVZWHJPLU[LZ
Características
.Y\WV
5‚TLYVKLWHJPLU[LZ
,KHK
:L_VMLTLUPUV
:LUZPIPSPaHJP}U
Ácaros
Mascotas
*VUQ\U[P]P[PZ
9PUP[PZ
Promedio exacerbación
persona / mes
4
*
3.5
Activo
Control
¶ *
*
*
*
3.1
3 3.2
2.5
2.4
1.9
2
1.5
1.4
1
1.7
1.8
1.6
1.1
1.2
3
4
0.9
0.5
0
0
1
2
Año
5
-PN\YH5‚TLYVKLL_HJLYIHJPVULZWYVTLKPVWVY
WHJPLU[LHSTLZLUSVZNY\WVZHJ[P]VHa\S`JVU[YVS
YVQVp#
[LUxH[YLZL_HJLYIHJPVULZTLUZ\HSLZ,UHTIVZ
NY\WVZ O\IV \UH YLK\JJP}U ZPNUPÄJH[P]H LU SH
MYLJ\LUJPHKLL_HJLYIHJPVULZKLHZTH-PN\YH
S\LNV KLS ZL_[V TLZ p$ ,U LS NY\WV
HJ[P]VSHKPZTPU\JP}UKLSHZL_HJLYIHJPVULZM\L
Z\WLYPVYHSNY\WVJVU[YVSHWHY[PYKLSUV]LUVTLZ
(p$3\LNVKL[YHZJ\YYPKVZKVZH|VZKLSH
Z\ZWLUZP}UKLSHPUT\UV[LYHWPHUVZLVIZLY]}
\UHYLJHxKHZPNUPÄJH[P]HLULSNY\WVHJ[P]V`LS
U‚TLYVKLL_HJLYIHJPVULZZLN\xHZPLUKVPUMLYPVY
X\LLULSNY\WVJVU[YVS
Reducción del consumo de medicamentos
(TIVZ NY\WVZ L_WLYPTLU[HYVU \UH YLK\JJP}U
PTWVY[HU[L KL SH TLKPJHJP}U YLX\LYPKH WHYH LS
Mé xic o
JVU[YVSKLSVZZxU[VTHZHWHY[PYKLSUV]LUVTLZ
`M\LKLWLUKPLU[LKLSHKVZPZKLPUOHSHKVYLZ5V
ZLVIZLY]HYVUKPMLYLUJPHZLUJ\HU[VHSJVUZ\TV
KLHU[PSL\JV[YPLUVZ,Z[HYLK\JJP}UM\LZPNUPÄJH[P]HTLU[LTH`VYLULSNY\WVHJ[P]V-PN\YH(S
ÄUHSPaHYSHPUT\UV[LYHWPH WHJPLU[LZ
OHIxHUZ\ZWLUKPKVSHHWSPJHJP}UKLPUOHSHKVYLZ
IYVUX\PHSLZLZ[LYVPKLZZVSVZVJVTIPUHKVZJVU
IL[HHNVUPZ[HZKLHJJP}USHYNHLUJVTWHYHJP}U
JVU KLSNY\WVJVU[YVSp$-PN\YH5VZLVIZLY]}\UHYLJHxKHZPNUPÄJH[P]H
LULSNY\WVHJ[P]VKLZW\tZKLSHZ\ZWLUZP}UKLSH
PUT\UV[LYHWPH-PN\YH5VO\IVKPMLYLUJPHZZPNUPÄJH[P]HZLU[YLSVZNY\WVZLUJ\HU[VHWHJPLU[LZ
X\LYLX\PYPLYVUH\TLU[VKLS[YH[HTPLU[VHSVZ[YLZ
H|VZHJ[P]VvsJVU[YVSVHSVZH|VZ
(3 vs UPKLMVYTHHJ\T\SHKH]Z
Edad y sensibilización como factores pronósticos
de la inmunoterapia
(SOHJLYLSHUmSPZPZKLSVZZ\INY\WVZLULSNY\WV
HJ[P]VJVUIHZLLUSHLKHK`U‚TLYVKLZLUZP-
*
*
100%
100% 100%
90%
80%
72%
65%
70%
63%60%
59%
60%
54%
42% 43%
50%
40% 40%
40%
30%
20%
10%
0%
Activo
Control
**
-PN\YH9LK\JJP}UKLTLKPJHTLU[VZLULS[PLTWV
KLZLN\PTPLU[V,SWVYJLU[HQLYLWYLZLU[HLSWYVTLKPV
KLSHKVZPZKLPUOHSHKVYLZYLJPIPKHLUYLSHJP}UJVU
SHKVZPZHKTPUPZ[YHKHHSPUPJPVKLSLZ[\KPV3HIHYYH
negra es el basal, las barras grises representan los tres
WYPTLYVZH|VZ`SHZTVYHKHZSVZKVZH|VZZPN\PLU[LZH
SHZ\ZWLUZP}UKLSHPUT\UV[LYHWPHLULSNY\WVHJ[P]V
p#p<0.01.
117
2016 abril-junio;63(2)
Revista Alergia México
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
PUOHSHKVZLU WHJPLU[LZ,U[VKVZSVZJHZVZZL
JVUZPN\P}SHYLTPZP}UKLSVZZxU[VTHZ`UVM\L
ULJLZHYPVZ\ZWLUKLYLS[YH[HTPLU[V
DISCUSIÓN
**
**
40%
38%
22%
3 años
Activo
23%
5 años
Control
-PN\YH:\ZWLUZP}U[V[HSKLPUOHSHKVYLZIYVUX\PHSLZ
HSVZ`H|VZ.Y\WVHJ[P]VHa\S`NY\WVJVU[YVS
YVQVp<0.01.
IPSPaHJPVULZ ZL VIZLY]} X\L SVZ WHJPLU[LZ KLS
NY\WVHJ[P]VTLUVYLZKLH|VZ[\]PLYVUTH`VY
YLK\JJP}ULUSHKVZPÄJHJP}UKLSVZPUOHSHKVYLZ`
TH`VYZ\ZWLUZP}U[V[HSX\LSVZV[YVZZ\INY\WVZ"
ZVIYL[VKVJ\HUKVZLJVTWHYHYVUJVULSNY\WV
WVSPZLUZPIPSPaHKVTH`VYKLH|VZ,ULS*\HKYV
ZLT\LZ[YHSHJVTWHYHJP}UKLZ\INY\WVZLU
LSNY\WVHJ[P]V
Efectos adversos durante el seguimiento
,U WHJPLU[LZ O\IV YLHJJPVULZ SVJHSLZ
PUTLKPH[HZTLUVZKL\UHOVYHKLZW\tZKLSH
HKTPUPZ[YHJP}UKLSHPUT\UV[LYHWPHKLLSSHZ
LULS[YHUZJ\YZVKLSHZWYPTLYHZKVZPZ\UHWVY
TLZ3HZYLHJJPVULZJVUZPZ[PLYVULULYP[LTH`
WY\YP[VLULSZP[PVKLHWSPJHJP}U`YLTP[PLYVULU
los primeros 60 minutos siguientes a la aparición.
:LYLWVY[HYVUJ\H[YVYLHJJPVULZZPZ[tTPJHZX\L
ZL JVU[YVSHYVU K\YHU[L SH H[LUJP}U ` JVU HS[H
WHYHSVZWHJPLU[LZ[YHUZJ\YYPKHZHOVYHZKL
VIZLY]HJP}UZPUJVTWSPJHJPVULZ[HYKxHZWVZ[LYPVYLZ;VKVZSVZWHJPLU[LZJVU[PU\HYVUJVULS
[YH[HTPLU[V3H[HZHKLHWLNVU‚TLYVKLJP[HZ
WHYHPUT\UV[LYHWPHJ\TWSPKHZM\LKL:L
YLWVY[HYVUKLYLHJJPVULZSVJHSLZLULSmYLH
WLYPI\JHS X\Pam HZVJPHKHZ JVU SVZ LZ[LYVPKLZ
+LIPKVHSHHS[HMYLJ\LUJPH`HSJHYmJ[LYJY}UPJV
KLSHZTHSVZJVZ[VZKLS[YH[HTPLU[VZVULSL]HKVZ
WHYHLSWHJPLU[L`LSZPZ[LTHKLZHS\KJVUSHZ
TVSLZ[PHZLPUJVU]LUPLU[LZX\LLSSVPTWSPJH7VY
LZ[VLSHZTHYLWYLZLU[H\UWYVISLTHKLZHS\K
W‚ISPJH`\UHULJLZPKHKKLPKLU[PÄJHYSHZMVYTHZ
KL[YH[HTPLU[VX\LYLZ\S[LUTmZJVZ[VLMLJ[P]HZ
WHYHLSWHJPLU[L`SVZZLY]PJPVZW‚ISPJVZKLZHS\K
+P]LYZVZ LZ[\KPVZ Z\Z[LU[HU X\L SH PUT\UV[LYHWPHLZLMLJ[P]HLULSJVU[YVSKLSHZTHSVX\L
WLYTP[LYLK\JPYSHULJLZPKHKKLTLKPJHTLU[VZ
JVU[YVSHKVYLZ SHZ HZPZ[LUJPHZ H \YNLUJPHZ \
OVZWP[HSPaHJPVULZ ` V[YVZ Y\IYVZ KLYP]HKVZ KL
SHH[LUJP}UKPYLJ[HLPUKPYLJ[HKLLZ[VZWHJPLUtes. (KLTmZZPLZHKTPUPZ[YHKHHUP|VZ
JVUYPUP[PZHStYNPJHKPZTPU\`LZPNUPÄJH[P]HTLU[L
LS YPLZNV KL WHKLJLY HZTH PUJS\ZV S\LNV KL
OHILYZ\ZWLUKPKVLS[YH[HTPLU[V(WLZHYKL
LZ[VZYLZ\S[HKVZLUT\JOHZVJHZPVULZLSPUPJPV
KLLZ[L[YH[HTPLU[VUVZLVMYLJLLUSVZZPZ[LTHZ
KLZHS\KVZ\PUPJPVLZT\JOVZH|VZKLSHHWHYPJP}UKLSVZZxU[VTHZSVX\LOHJLX\LZ\LMLJ[V
JSxUPJVKPZTPU\`H22
,ULZ[LLZ[\KPVZLL]HS\}LSJVU[YVSZPU[VTm[PJV
KL\UNY\WVKLWHJPLU[LZJVUHZTHK\YHU[LSVZ
[YLZH|VZKLS[YH[HTPLU[VJVUPUT\UV[LYHWPH`
KVZH|VZWVZ[LYPVYLZHZ\Z\ZWLUZP}U:LVIZLY]}
X\L\UWVYJLU[HQLPTWVY[HU[LKLSVZWHJPLU[LZ
KLS NY\WV HJ[P]V ` JVU[YVS [\]PLYVU TLQVY YLZW\LZ[H JSxUPJH JVU TLUVZ L_HJLYIHJPVULZ `
TLUVYULJLZPKHKKLTLKPJHTLU[VZJVU[YVSHKVYLZ,SLMLJ[VKLLZ[HZKVZ]HYPHISLZKLL]HS\HJP}U
M\L TmZ WYVU\UJPHKV LU LS NY\WV X\L YLJPIP}
PUT\UV[LYHWPH HU[LZ KLS WYPTLY H|V KL HKTPUPZ[YHJP}U ,Z[L LMLJ[V JSxUPJV ZL THU[\]V WVY
LZWHJPVKLKVZH|VZWVZ[LYPVYLZHSHZ\ZWLUZP}U
SVX\LPUKPJHX\LLZZPTPSHYHSVWYL]PHTLU[LYL-
Re vista
Mé xic o
Sánchez J y col. Impacto de la inmunoterapia con alergenos después de su suspensión
*\HKYV ,KHKKLSVZWHJPLU[LZ`WH[Y}UKLZLUZPIPSPaHJP}U
.Y\WVHJ[P]VU$
4LUVYLZKLH|VZU$
4H`VYLZKLH|VZU$
4:#U$
7:#U$
4:%U$
7:%U$
(\TLU[VKLPUOHSHKVYLZ
9LK\JJP}UKLPUOHSHKVYLZ
:\ZWLUZP}UKLPUOHSHKVYLZ
P
0.1
0.03
9LZ\S[HKVZHSÄUHSPaHYLSLZ[\KPV
(\TLU[VHJ\T\SH[P]VKLZW\tZKLJPUJVH|VZLULS[V[HSKLWHJPLU[LZU$
7VYJLU[HQL LU LS [V[HS KL WHJPLU[LZ LU YLSHJP}U JVU LS LZ[HKV IHZHS H SVZ H|VZ U$ 4:! TVUVZLUZPIPSPaHKVZ 7:!
WVSPZLUZPIPSPaHKVZ
WVY[HKVLUYPUP[PZ3HPUT\UV[LYHWPHWLYTP[L\UH
PUT\UVTVK\SHJP}UX\LWLYK\YHLULS[PLTWV
3HZ ]HYPHISLZ KL L]HS\HJP}U \[PSPaHKHZ ZL YLSHJPVUHUJVUNHZ[VZLJVU}TPJVZKPYLJ[VZWHYHLS
WHJPLU[LHZPZ[LUJPHH\YNLUJPHZKVZPZKLSHTLKPJHJP}UZ\ZWLUZP}UKLPUOHSHKVYLZL[JSVX\L
WLYTP[LL_WSVYHYLSLMLJ[VKLSHPUT\UV[LYHWPHLU
YLSHJP}UJVUZ\JVZ[VLMLJ[P]PKHK3VZYLZ\S[HKVZ
KLLZ[LLZ[\KPVZVUZPTPSHYLZHSVZLUJVU[YHKVZ
LUSHYL]PZP}UKLHY[xJ\SVZW\ISPJHKVZLUKVUKL
SHTH`VYWHY[LKLSHZL]HS\HJPVULZLJVU}TPJHZ
JVUJS\`LUX\LSHPUT\UV[LYHWPHJVUHStYNLUVZ
YLK\JLSVZJVZ[VZKLS[YH[HTPLU[VKLSHZHSLYNPHZ
[HU[VKLZKLSHWLYZWLJ[P]HKLSWHJPLU[LJVTVKLS
[LYJLYWHNHKVYZPZ[LTHKLZHS\K ZVIYL[VKV
LUWHJPLU[LZJVUYPUP[PZ`HZTH(KLTmZLZ\UH
TLKPKH JVZ[VLMLJ[P]H LU JVTWHYHJP}U JVU LS
[YH[HTPLU[VJVU]LUJPVUHSJVUMmYTHJVZSVX\L
LZTmZL]PKLU[LJ\HUKVLZ[HYLSHJP}UZLL_WYLZH
JVTV JVZ[VLMLJ[P]PKHK PUJYLTLU[HS 0*,930
3H OL[LYVNLULPKHK LU SH TL[VKVSVNxH KL SVZ
LZ[\KPVZ`SHZWVISHJPVULZLZ[\KPHKHZSPTP[HUSHZ
NLULYHSPaHJPVULZKLZ\ZJVUJS\ZPVULZ
3H YLSHJP}U JVZ[VLMLJ[P]PKHK KL SH PUT\UV[LYHWPH KLWLUKL KL SH K\YHJP}U KLS ILULÄJPV
JSxUPJVKLZW\tZKL[LYTPUHYLS[YH[HTPLU[V`KL
SVZJVZ[VZHJ\T\SHKVZKLSHPUT\UV[LYHWPH`KL
SVZTLKPJHTLU[VZ(SLTWLaHYSHPUT\UV[LYHWPH
SVZ JVZ[VZ KL [YH[HTPLU[V ZVU TH`VYLZ WVYX\L
SVZ KL SH PUT\UV[LYHWPH ZL H|HKLU WLYV UV
YLLTWSHaHU HS [YH[HTPLU[V JVU]LUJPVUHS JVU
MmYTHJVZ ,S W\U[V KL LX\PSPIYPV ZL JVUZPN\L
J\HUKVZLYLK\JLLSU‚TLYVKLTLKPJHTLU[VZ
\[PSPaHKVZ`J\HUKVZL[LYTPUHSHPUT\UV[LYHWPH
,Z[VZW\U[VZZVU]HYPHISLZWLYVNLULYHSTLU[L
LSW\U[VKLLX\PSPIYPVZLKHHU[LZKLSZLN\UKV
H|V`SHZ\ZWLUZP}UKLSHPUT\UV[LYHWPHLU[YL
LS[LYJLYV`X\PU[VH|VZKLZW\tZKLSPUPJPV7VY
LZ[HYHa}USVZTVKLSVZLJVU}TPJVZKLPUT\UV[LYHWPHZLWYV`LJ[HUH\UOVYPaVU[L[LTWVYHSKL
TmZKLJPUJVH|VZ31,32
:PIPLUKLZKL[VKHZSHZWLYZWLJ[P]HZZLJVPUJPKL
LUX\LSHPUT\UV[LYHWPHLZJVZ[VLMLJ[P]HtZ[H
LZTH`VYKLZKLSHKLSWHJPLU[LW\LZLZX\PLU
HZ\TL SVZ JVZ[VZ PUKPYLJ[VZ KL SH LUMLYTLKHK
HIZ[LUJPVUPZTVSHIVYHSVLZJVSHYKLSWHJPLU[L`
KLZ\NY\WVZVJPHSX\LZLN‚UHSN\UVZLZ[\KPVZ
W\LKLYLWYLZLU[HYSHTH`VYWHY[LKLSVZNHZ[VZ
HZVJPHKVZJVUSHLUMLYTLKHK
7\LZ[VX\LSHZYL]PZPVULZZPZ[LTm[PJHZKLS[LTH
ZL IHZHU LU LZ[\KPVZ W\ISPJHKVZ LU WHxZLZ KL
,\YVWH ` ,Z[HKVZ <UPKVZ LZ LZWLYHKV X\L ZL
HUHSPJLU LU Z\ TH`VYxH LZ[\KPVZ KL PUT\UV[LYHWPHWHYHWVSLUVmYIVSLZ33`ZVUWVJVZSVZ
HY[xJ\SVZPUJS\PKVZX\LL]HS‚HUSHYLWLYJ\ZP}U
LJVU}TPJHKLSHPUT\UV[LYHWPHJVUmJHYVZLU
asma.(KLTmZSHZJVUJS\ZPVULZKLSVZLZ[\KPVZMmYTHJVLJVU}TPJVZW\LKLU]HYPHYKL\U
S\NHYHV[YVW\LZLU[tYTPUVZTmZJ\HU[P[H[P]VZ
`LZWLJxÄJVZSHJVZ[VLMLJ[P]PKHKKLWLUKLKLS
119
2016 abril-junio;63(2)
Revista Alergia México
[PWVKLWVISHJP}U"W\LKLU]HYPHYLSJVZ[VKLSH
PUT\UV[LYHWPH`LSKLSHWYVK\J[P]PKHKSHIVYHS
WLYKPKH
TmZZL]LYVX\LZLYLÅLQHLUTH`VYU‚TLYVKL
ZLUZPIPSPaHJPVULZ`LU[YH[HTPLU[VJSxUPJVTmZ
complejo.
,ZYLJVTLUKHISLX\LLUJHKHWHxZZLYLHSPJL\UH
]HSVYHJP}UKLSH[LJUVSVNxHLU[tYTPUVZKLZ\
ZP[\HJP}UZVJPHS`LJVU}TPJHWYLJPZHTLU[LWVY
LZ[HYHa}UU\LZ[YVZYLZ\S[HKVZZVUPTWVY[HU[LZ
WHYH3H[PUVHTtYPJHWVYX\LL_WSVYHYHUSHYLWLYJ\ZP}U KL SH PUT\UV[LYHWPH LU \UH WVISHJP}U
JVU HZTH LU JVUKPJPVULZ ZVJPVKLTVNYmÄJHZ
ZPTPSHYLZ H SHZ YLWVY[HKHZ LU SHZ WYPUJPWHSLZ
JP\KHKLZ[YVWPJHSLZKLSHYLNP}U`X\L[HS]LaZL
ZLTLQLUTLQVYSHZYLHSPKHKLZZVJPVLJVU}TPJHZ
KL SH YLNP}U LU JVTWHYHJP}U JVU SVZ LZ[\KPVZ
WYV]LUPLU[LZKL,Z[HKVZ<UPKVZV,\YVWH
5\LZ[YVLZ[\KPV[PLUL]HYPHZSPTP[HJPVULZZLJ\UKHYPHZHZ\KPZL|VVIZLY]HJPVUHS`SHH\ZLUJPH
KLJPLNV,U[YLSHZMVY[HSLaHZLZ[mLSSHYNV[PLTWV
KLL]HS\HJP}UH|VZ`X\LHSZLYVIZLY]HJPVUHS UV PU[LY]LUJPVUPZ[H WLYTP[L HWYLJPHY KL
THULYHVIQL[P]HSVZJHTIPVZLUSVZWHYmTL[YVZ
L]HS\HKVZLULS[PLTWVLUSH]PKHYLHS,S\ZV
KL ]HYPHISLZ KL L]HS\HJP}U VIQL[P]HZ WLYTP[P}
\U ZLN\PTPLU[V HKLJ\HKV ` JVUÄHISL KL SVZ
WHYmTL[YVZL]HS\HKVZ
,ULZ[LLZ[\KPVZVSVZLPUJS\`LYVUWHJPLU[LZJVU
HS[HZVZWLJOHJSxUPJHKLZxU[VTHZHSL_WVULYZLH
SVZmJHYVZ`JVUPUPJPVKLSHLUMLYTLKHKK\YHU[L
SHWYPTLYHKtJHKHKLSH]PKH"HZxW\KVJVUZLN\PYZL \UH T\LZ[YH OVTVNtULH KL WHJPLU[LZ
JVUYLZWLJ[VHSHOPZ[VYPHJSxUPJH(SPUJS\PY\U
NY\WV JVU[YVS W\KPLYVU JVTWHYHYZL SHZ KPMLYLUJPHZLUSHYLZW\LZ[HJSxUPJHZLJ\UKHYPHZHSH
PUT\UV[LYHWPHVHS[YH[HTPLU[VMHYTHJVS}NPJV
` OHJLY HUmSPZPZ KL Z\INY\WVZ ZLN‚U SH LKHK
` LS LZ[HKV KL ZLUZPIPSPaHJP}U :PTPSHY H \UH
VIZLY]HJP}UWYL]PHTLU[LYLWVY[HKHWVYU\LZ[YV
grupo22VIZLY]HTVZX\LSHLKHKKLPUPJPVKLSH
PUT\UV[LYHWPH`LSU‚TLYVKLZLUZPIPSPaHJPVULZ
PUÅ\`L LU SH YLZW\LZ[H JSxUPJH HS [YH[HTPLU[V
PUT\UVTVK\SHKVY3HTLQVYxHJSxUPJHLUJVU[YHKH LU SVZ WHJPLU[LZ WVSPZLUZPIPSPaHKVZ HS
HKTPUPZ[YHY\UHZVSHM\LU[LKLHStYNLUVZPUKPJH
X\LUVLZULJLZHYPVHKTPUPZ[YHY]HYPHZM\LU[LZ
WHYHVI[LULY\ULMLJ[VJSxUPJVZPUVYLHSPaHY\UH
HKLJ\HKHL]HS\HJP}UKPHNU}Z[PJHX\LWLYTP[H
PKLU[PÄJHYSHM\LU[LYLSL]HU[LLUSVZZxU[VTHZ
KLS WHJPLU[L :PU LTIHYNV LZ YLJVTLUKHISL
HKTPUPZ[YHYLS[YH[HTPLU[VKLMVYTH[LTWYHUH
WHYHKPZTPU\PYLSU‚TLYVKLU\L]HZZLUZPIPSPaHJPVULZ,STH`VY[PLTWVKLL_WVZPJP}UHM\LU[LZ
KLHStYNLUVZWYVK\JL\UWYVJLZVPUÅHTH[VYPV
120
,UYLZ\TLUVIZLY]HTVZX\LSHPUT\UV[LYHWPH
es un tratamiento útil en los pacientes con asma
KLL[PVSVNxHHStYNPJH`X\LZ\ZLMLJ[VZJSxUPJVZ
WLYK\YHUTmZHSSmKLZ\Z\ZWLUZP}UHSPN\HSX\L
JVUÄYTHTVZX\LSHLKHKKLPUPJPV`LSU‚TLYV
KLZLUZPIPSPaHJPVULZZVUMHJ[VYLZKLJPZP]VZLU
SH YLWLYJ\ZP}U JSxUPJH KLS [YH[HTPLU[V ,Z[VZ
YLZ\S[HKVZ W\LKLU ZLY]PY KL W\U[V KL WHY[PKH
WHYHLZ[\KPVZKLJVZ[VLÄJHJPHLUSHYLNP}UKLS
[Y}WPJVX\LWLYTP[HULZ[HISLJLYZPSHPUT\UV[LYHWPHKLILZLYPTWSLTLU[HKHJVTVWVSx[PJH
KLZHS\K
Agradecimientos
,UTLTVYPHKLSH+YH,SPaHIL[O3}WLaX\PLU
JVSHIVY}HJ[P]HTLU[LLUSHYLJVSLJJP}U`ZLN\PTPLU[VKLSVZWHJPLU[LZ
Fuente de financiación:
,Z[L [YHIHQV M\L ÄUHUJPHKV JVU YLJ\YZVZ KL SH
<UP]LYZPKHKKL(U[PVX\PH`KLSH07:<UP]LYZP[HYPHKLSH<UP]LYZPKHKKL(U[PVX\PH
REFERENCIAS
1.
ĞŶŶŝƐZ͕ĂƌĂďĂůůŽ>͕'ĂƌĐŝĂ͕ĂďĂůůĞƌŽ͕ƌŝƐƟnjĂďĂů'͕
ŽƌĚŽďĂ,͕ĞƚĂů͘ƐƚŚŵĂĂŶĚŽƚŚĞƌĂůůĞƌŐŝĐĐŽŶĚŝƟŽŶƐŝŶ
Re vista
Sánchez J y col. Impacto de la inmunoterapia con alergenos después de su suspensión
Mé xic o
2.
Vergara C, Caraballo L. Asthma mortality in Columbia. Ann
ůůĞƌŐLJƐƚŚŵĂ/ŵŵƵŶŽů͘ϭϵϵϴ͖ϴϬ;ϭͿ͗ϱϱͲϲϬ͘
18. ŽŵƉĂůĂƟ͕WĂƐƐĂůĂĐƋƵĂ'͕ŽŶŝŶŝD͕ĂŶŽŶŝĐĂ't͘dŚĞ
ĞĸĐĂĐLJŽĨƐƵďůŝŶŐƵĂůŝŵŵƵŶŽƚŚĞƌĂƉLJĨŽƌŚŽƵƐĞĚƵƐƚŵŝƚĞƐ
respiratory allergy: results of a GA2LEN meta-analysis.
ůůĞƌŐLJ͘ϮϬϬϵ͖ϲϰ;ϭϭͿ͗ϭϱϳϬͲϵ͘
3.
EĞīĞŶ,͕ĂĞŶĂͲĂŐŶĂŶŝ͕DĂůŬĂ^͕^ŽůĞ͕^ĞƉƵůǀĞĚĂ
Z͕ĂƌĂďĂůůŽ>͕ĞƚĂů͘ƐƚŚŵĂŵŽƌƚĂůŝƚLJŝŶ>ĂƟŶŵĞƌŝĐĂ͘:
/ŶǀĞƐƟŐůůĞƌŐŽůůŝŶ/ŵŵƵŶŽů͘ϭϵϵϳ͖ϳ;ϰͿ͗ϮϰϵͲϱϯ͘
ϭϵ͘ ďƌĂŵƐŽŶ D:͕ WƵLJ ZD͕ tĞŝŶĞƌ :D͘ /ŶũĞĐƟŽŶ ĂůůĞƌŐĞŶ
immunotherapy for asthma. Cochrane Database Syst Rev.
ϮϬϭϬ;ϴͿ͗ϬϬϭϭϴϲ͘
4.
ĚĞƌt͕ŐĞD:͕ǀŽŶDƵƟƵƐ͘dŚĞĂƐƚŚŵĂĞƉŝĚĞŵŝĐ͘E
ŶŐů:DĞĚ͘ϮϬϬϲ͖ϯϱϱ;ϮϭͿ͗ϮϮϮϲͲϯϱ͘
5.
Anandan C, Nurmatov U, van Schayck O, Sheikh A. Is the
ƉƌĞǀĂůĞŶĐĞ ŽĨ ĂƐƚŚŵĂ ĚĞĐůŝŶŝŶŐ͍ ^LJƐƚĞŵĂƟĐ ƌĞǀŝĞǁ ŽĨ
ĞƉŝĚĞŵŝŽůŽŐŝĐĂůƐƚƵĚŝĞƐ͘ůůĞƌŐLJ͘ϮϬϭϬ͖ϲϱ;ϮͿ͗ϭϱϮͲϲϳ͘
20. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken
^͕ ,ƆƐƚ ͕ Ğƚ Ăů͘ ^ƉĞĐŝĮĐ ŝŵŵƵŶŽƚŚĞƌĂƉLJ ŚĂƐ ůŽŶŐͲƚĞƌŵ
ƉƌĞǀĞŶƟǀĞĞīĞĐƚŽĨƐĞĂƐŽŶĂůĂŶĚƉĞƌĞŶŶŝĂůĂƐƚŚŵĂ͗ϭϬͲ
LJĞĂƌĨŽůůŽǁͲƵƉŽŶƚŚĞWdƐƚƵĚLJ͘ůůĞƌŐLJ͘ϮϬϬϳ͖ϲϮ;ϴͿ͗ϵϰϯͲϴ͘
ŽůŽŵďŝĂ͗ĂƐƚƵĚLJŝŶϲĐŝƟĞƐ͘ŶŶůůĞƌŐLJƐƚŚŵĂ/ŵŵƵŶŽů͘
ϮϬϬϰ͖ϵϯ;ϲͿ͗ϱϲϴͲϳϰ͘
ϲ͘
Caraballo L, Acevedo N. Allergy in the tropics: the impact
ŽĨĐƌŽƐƐͲƌĞĂĐƟǀŝƚLJďĞƚǁĞĞŶŵŝƚĞƐĂŶĚĂƐĐĂƌŝƐ͘&ƌŽŶƚŝŽƐĐŝ
;ůŝƚĞĚͿ͘ϮϬϭϭ͖ϯ͗ϱϭͲϲϰ͘
7.
Burbach G, Heinzerling L, Edenharter G, Bachert C,
Bindslev-Jensen C, Bonini S, et al. GA(2)LEN skin test study
//͗ĐůŝŶŝĐĂůƌĞůĞǀĂŶĐĞŽĨŝŶŚĂůĂŶƚĂůůĞƌŐĞŶƐĞŶƐŝƟnjĂƟŽŶƐŝŶ
ƵƌŽƉĞ͘ůůĞƌŐLJ͘ϮϬϬϵ͖ϲϰ;ϭϬͿ͗ϭϱϬϳͲϭϱ͘
8.
^ĄŶĐŚĞnj:͕ŝĞnj^͕ĂƌĚŽŶĂZ͘΀&ƌĞƋƵĞŶĐLJŽĨƐĞŶƐŝƟnjĂƟŽŶƚŽ
ĂŶŝŵĂůƐŝŶĂƚƌŽƉŝĐĂůĂƌĞĂ΁͘ZĞǀůĞƌŐDĞdž͘ϮϬϭϰ͖ϲϭ;ϮͿ͗ϴϭͲϵ͘
ϵ͘
Sanchez J, Diez S, Cardona R. Sensibilización a aeroalergenos en pacientes alérgicos de Medellín, Colombia Revista
ůĞƌŐŝĂDĠdžŝĐŽ͘ϮϬϭϮ͖ϱϵ;ϯͿ͗ϭϯϵͲϰϳ͘
10. &ĂƐĐĞ>͕dŽƐĐĂD͕ĂƌŽĸŽD͕KůĐĞƐĞZ͕ŝƉƌĂŶĚŝ'͘ƚŽƉLJ
ŝŶǁŚĞĞnjŝŶŐŝŶĨĂŶƚƐĂůǁĂLJƐƐƚĂƌƚƐǁŝƚŚŵŽŶŽƐĞŶƐŝƟnjĂƟŽŶ͘
ůůĞƌŐLJƐƚŚŵĂWƌŽĐ͘ϮϬϬϳ͖Ϯϴ;ϰͿ͗ϰϰϵͲϱϯ͘
11. ůnjĂŬĂƌZ,͕ůƐĂŵĂƌĂŝD͘ĸĐĂĐLJŽĨŝŵŵƵŶŽƚŚĞƌĂƉLJĨŽƌ
treatment of allergic asthma in children. Allergy Asthma
Proc. 2010;31(4):324-30.
12. Cox L. Allergen immunotherapy and asthma: efficacy,
ƐĂĨĞƚLJ͕ ĂŶĚ ŽƚŚĞƌ ĐŽŶƐŝĚĞƌĂƟŽŶƐ͘ ůůĞƌŐLJ ƐƚŚŵĂ WƌŽĐ͘
ϮϬϬϴ͖Ϯϵ;ϲͿ͗ϱϴϬͲϵ͘
13. ĂĚLJ ͕ WŽǁĞůů D͕ ,ĂƌďĞĐŬ Z͕ 'ŝĐůĂƐ W͕ DƵƌƉŚLJ :͕ <ĂƟĂů
Z͕ Ğƚ Ăů͘ /Ő' ĂŶƟďŽĚŝĞƐ ƉƌŽĚƵĐĞĚ ĚƵƌŝŶŐ ƐƵďĐƵƚĂŶĞŽƵƐ
ĂůůĞƌŐĞŶ ŝŵŵƵŶŽƚŚĞƌĂƉLJ ŵĞĚŝĂƚĞ ŝŶŚŝďŝƟŽŶ ŽĨ ďĂƐŽƉŚŝů
ĂĐƟǀĂƟŽŶǀŝĂĂŵĞĐŚĂŶŝƐŵŝŶǀŽůǀŝŶŐďŽƚŚ&ĐŐĂŵŵĂZ//
ĂŶĚ&ĐŐĂŵŵĂZ//͘/ŵŵƵŶŽů>ĞƩ͘ϮϬϭϬ͖ϭϯϬ;ϭͲϮͿ͗ϱϳͲϲϱ͘
14. tŝŶŐ <͕ ^ĂŬĂŐƵĐŚŝ ^͘ ZĞŐƵůĂƚŽƌLJ d ĐĞůůƐ ĂƐ ƉŽƚĞŶƟĂů ŝŵmunotherapy in allergy. Curr Opin Allergy Clin Immunol.
ϮϬϬϲ͖ϲ;ϲͿ͗ϰϴϮͲϴ͘
15. Pauli G, Larsen TH, Rak S, Horak F, Pastorello E, Valenta R,
ĞƚĂů͘ĸĐĂĐLJŽĨƌĞĐŽŵďŝŶĂŶƚďŝƌĐŚƉŽůůĞŶǀĂĐĐŝŶĞĨŽƌƚŚĞ
ƚƌĞĂƚŵĞŶƚŽĨďŝƌĐŚͲĂůůĞƌŐŝĐƌŚŝŶŽĐŽŶũƵŶĐƟǀŝƟƐ͘:ůůĞƌŐLJůŝŶ
/ŵŵƵŶŽů͘ϮϬϬϴ͖ϭϮϮ;ϱͿ͗ϵϱϭͲϲϬ͘
ϭϲ͘ ŽƉĞŶŚĂǀĞƌ͕WĂƌŬĞƌ͕WĂƚĐŚ^͘^LJƐƚĞŵŝĐƌĞĂĐƟŽŶƐǁŝƚŚ
ĂĞƌŽĂůůĞƌŐĞŶĐůƵƐƚĞƌŝŵŵƵŶŽƚŚĞƌĂƉLJŝŶĂĐůŝŶŝĐĂůƉƌĂĐƟĐĞ͘
Ann Allergy Asthma Immunol. 2011;107(5):441-7.
17. WĞŶĂŐŽƐD͕WĂƐƐĂůĂĐƋƵĂ'͕ŽŵƉĂůĂƟ͕ĂĞŶĂͲĂŐŶĂŶŝ
͕KƌŽnjĐŽ^͕WĞĚƌŽnjĂ͕ĞƚĂů͘DĞƚĂĂŶĂůLJƐŝƐŽĨƚŚĞĞĸĐĂĐLJ
of sublingual immunotherapy in the treatment of allergic
ĂƐƚŚŵĂŝŶƉĞĚŝĂƚƌŝĐƉĂƟĞŶƚƐ͕ϯƚŽϭϴLJĞĂƌƐŽĨĂŐĞ͘ŚĞƐƚ͘
ϮϬϬϴ͖ϭϯϯ;ϯͿ͗ϱϵϵͲϲϬϵ͘
21. Möller C, Dreborg S, Ferdousi HA, Halken S, Høst A,
Jacobsen L, et al. Pollen immunotherapy reduces the
ĚĞǀĞůŽƉŵĞŶƚ ŽĨ ĂƐƚŚŵĂ ŝŶ ĐŚŝůĚƌĞŶ ǁŝƚŚ ƐĞĂƐŽŶĂů ƌŚŝŶŽĐŽŶũƵŶĐƟǀŝƟƐ ;ƚŚĞ WdͲƐƚƵĚLJͿ͘ : ůůĞƌŐLJ ůŝŶ /ŵŵƵŶŽů͘
ϮϬϬϮ͖ϭϬϵ;ϮͿ͗ϮϱϭͲϲ͘
22. Sánchez J, Restrepo M, Diez S, Cardona R. Comparación
del efecto clínico de la inmunoterapia en pacientes
con asma alérgica según la edad y el patrón de sensibilización. Alergia, Asma e Inmunología Pediátricas.
ϮϬϭϰ͖Ϯϯ;ϭͿ͗ϲͲϭϰ͘
23. ŽƵƐƋƵĞƚ:͕>ŽĐŬĞLJZ͕DĂůůŝŶŐ,:͘ůůĞƌŐĞŶŝŵŵƵŶŽƚŚĞƌĂƉLJ͗
ƚŚĞƌĂƉĞƵƟĐǀĂĐĐŝŶĞƐĨŽƌĂůůĞƌŐŝĐĚŝƐĞĂƐĞƐ͘t,KƉŽƐŝƟŽŶ
ƉĂƉĞƌ͘:ůůĞƌŐLJůŝŶ/ŵŵƵŶŽů͘ϭϵϵϴ͖ϭϬϮ;ϰWƚϭͿ͗ϱϱϴͲϲϮ͘
24. Heinzerling LM, Burbach GJ, Edenharter G, Bachert C,
Bindslev-Jensen C, Bonini S, et al. GA(2)LEN skin test study
/͗';ϮͿ>EŚĂƌŵŽŶŝnjĂƟŽŶŽĨƐŬŝŶƉƌŝĐŬƚĞƐƟŶŐ͗ŶŽǀĞůƐĞŶƐŝƟnjĂƟŽŶƉĂƩĞƌŶƐĨŽƌŝŶŚĂůĂŶƚĂůůĞƌŐĞŶƐŝŶƵƌŽƉĞ͘ůůĞƌŐLJ͘
ϮϬϬϵ͖ϲϰ;ϭϬͿ͗ϭϰϵϴͲϱϬϲ͘
25. ŝĞůĞŶ^͕<ĂƌĚŽƐW͕DĂĚŽŶŝŶŝ͘^ƚĞƌŽŝĚͲƐƉĂƌŝŶŐĞīĞĐƚƐǁŝƚŚ
ĂůůĞƌŐĞŶͲƐƉĞĐŝĮĐŝŵŵƵŶŽƚŚĞƌĂƉLJŝŶĐŚŝůĚƌĞŶǁŝƚŚĂƐƚŚŵĂ͗
a randomized controlled trial. J Allergy Clin Immunol.
ϮϬϭϬ͖ϭϮϲ;ϱͿ͗ϵϰϮͲϵ͘
Ϯϲ͘ <ǁŽŶz^͕KŚ^,͕tƵt,͕ĂĞ'͕>ĞĞ,:͕>ĞĞD'͕ĞƚĂů͘
ĐŚĞŵŽŬŝŶĞƐĂƐƉŽƚĞŶƟĂůŝŵŵƵŶŽůŽŐŝĐŵĂƌŬĞƌƐĐŽƌƌĞůĂƚĞĚ
ǁŝƚŚĐůŝŶŝĐĂůŝŵƉƌŽǀĞŵĞŶƚŽĨĂƚŽƉŝĐĚĞƌŵĂƟƟƐƉĂƟĞŶƚƐďLJ
ŝŵŵƵŶŽƚŚĞƌĂƉLJ͘džƉĞƌŵĂƚŽů͘ϮϬϭϬ͖ϭϵ;ϯͿ͗ϮϰϲͲϱϭ͘
27. ZŽƐƐŝZ͕DŽŶĂƐƚĞƌŽůŽ'͕/ŶĐŽƌǀĂŝĂ͕DŽŝŶŐĞŽŶW͕&ƌĂƟ&͕
WĂƐƐĂůĂĐƋƵĂ'͕ĞƚĂů͘>ĂĐŬŽĨŶĞŽͲƐĞŶƐŝƟnjĂƟŽŶƚŽWĞŶĂϭ
ŝŶƉĂƟĞŶƚƐƚƌĞĂƚĞĚǁŝƚŚŵŝƚĞƐƵďůŝŶŐƵĂůŝŵŵƵŶŽƚŚĞƌĂƉLJ͘
Clin Mol Allergy. 2010;8:4.
28. ĂŶƟůůŽ:&͕WƵĞƌƚĂ>͘΀EĞǁĂƉƉƌŽĂĐŚĞƐĨŽƌĂůůĞƌŐĞŶͲƐƉĞĐŝĮĐ
ŝŵŵƵŶŽƚŚĞƌĂƉLJ΁͘ŝŽŵĞĚŝĐĂ͘ϮϬϭϬ͖ϯϬ;ϯͿ͗ϰϰϬͲϱϯ͘
Ϯϵ͘ ^ŝŵŽĞŶƐ^͘dŚĞĐŽƐƚͲĞīĞĐƟǀĞŶĞƐƐŽĨŝŵŵƵŶŽƚŚĞƌĂƉLJĨŽƌ
ƌĞƐƉŝƌĂƚŽƌLJĂůůĞƌŐLJ͗ĂƌĞǀŝĞǁ͘ůůĞƌŐLJ͘ϮϬϭϮ͖ϲϳ;ϵͿ͗ϭϬϴϳͲϭϬϱ͘
30. DĞĂĚŽǁƐ͕<ĂĂŵďǁĂ͕EŽǀŝĞůůŝE͕,ƵŝƐƐŽŽŶ͕&ƌLJͲ^ŵŝƚŚ
͕ DĞĂĚƐ ͕ Ğƚ Ăů͘ ƐLJƐƚĞŵĂƟĐ ƌĞǀŝĞǁ ĂŶĚ ĞĐŽŶŽŵŝĐ
ĞǀĂůƵĂƟŽŶ ŽĨ ƐƵďĐƵƚĂŶĞŽƵƐ ĂŶĚ ƐƵďůŝŶŐƵĂů ĂůůĞƌŐĞŶ ŝŵŵƵŶŽƚŚĞƌĂƉLJŝŶĂĚƵůƚƐĂŶĚĐŚŝůĚƌĞŶǁŝƚŚƐĞĂƐŽŶĂůĂůůĞƌŐŝĐ
ƌŚŝŶŝƟƐ͘,ĞĂůƚŚdĞĐŚŶŽůŽŐLJƐƐĞƐƐŵĞŶƚ͘ϮϬϭϯ͖ϭϳ;ϮϳͿ͘
31. Bruggenjurgen B, Reinhold T, Brehler R, Laake E, Wiese G,
DĂĐŚĂƚĞh͕ĞƚĂů͘ŽƐƚͲĞīĞĐƟǀĞŶĞƐƐŽĨƐƉĞĐŝĮĐƐƵďĐƵƚĂŶĞŽƵƐŝŵŵƵŶŽƚŚĞƌĂƉLJŝŶƉĂƟĞŶƚƐǁŝƚŚĂůůĞƌŐŝĐƌŚŝŶŝƟƐĂŶĚ
allergic asthma. Annals of allergy, asthma & immunology:
121
Revista Alergia México
ŽĸĐŝĂů ƉƵďůŝĐĂƟŽŶ ŽĨ ƚŚĞ ŵĞƌŝĐĂŶ ŽůůĞŐĞ ŽĨ ůůĞƌŐLJ͕
ƐƚŚŵĂ͕Θ/ŵŵƵŶŽůŽŐLJ͘ϮϬϬϴ͖ϭϬϭ;ϯͿ͗ϯϭϲͲϮϰ͘
32. Hankin CS, Cox L, Bronstone A, Wang Z. Allergy immunotherapy: reduced health care costs in adults and
ĐŚŝůĚƌĞŶ ǁŝƚŚ ĂůůĞƌŐŝĐ ƌŚŝŶŝƚŝƐ͘ : ůůĞƌŐLJ ůŝŶ /ŵŵƵŶŽů͘
ϮϬϭϯ͖ϭϯϭ;ϰͿ͗ϭϬϴϰͲϵϭ͘
33. ,ĂŶŬŝŶ ^͕ Ždž >͘ ůůĞƌŐLJ ŝŵŵƵŶŽƚŚĞƌĂƉLJ͗ ǁŚĂƚ ŝƐ ƚŚĞ
evidence for cost saving? Curr Opin Allergy Clin Immunol.
ϮϬϭϰ͖ϭϰ;ϰͿ͗ϯϲϯͲϳϬ͘
122
2016 abril-junio;63(2)
34. Reinhold T, Ostermann J, Thum-Oltmer S, Bruggenjurgen B.
/ŶŇƵĞŶĐĞŽĨƐƵďĐƵƚĂŶĞŽƵƐƐƉĞĐŝĮĐŝŵŵƵŶŽƚŚĞƌĂƉLJŽŶĚƌƵŐ
ĐŽƐƚƐŝŶĐŚŝůĚƌĞŶƐƵīĞƌŝŶŐĨƌŽŵĂůůĞƌŐŝĐĂƐƚŚŵĂ͘ůŝŶŝĐĂůĂŶĚ
ƚƌĂŶƐůĂƟŽŶĂůĂůůĞƌŐLJ͘ϮϬϭϯ͖ϯ;ϭͿ͗ϯϬ͘
35. ŚĞŶ:͕yŝĂŶŐ:͕tĂŶŐz͕^ŚŝY͕dĂŶ,͕<ŽŶŐt͘΀,ĞĂůƚŚ
ĞĐŽŶŽŵŝĐƐĂŶĂůLJƐŝƐŽĨƐƉĞĐŝĮĐŝŵŵƵŶŽƚŚĞƌĂƉLJŝŶĂůůĞƌŐŝĐ
ƌŚŝŶŝƟƐĂĐĐŽŵƉĂŶŝĞĚǁŝƚŚĂƐƚŚŵĂ΁͘>ŝŶĐŚƵĂŶŐĞƌďŝLJĂŶ
ŚŽƵƚŽƵũŝŶŐǁĂŝŬĞnjĂnjŚŝс:ŽƵƌŶĂůŽĨĐůŝŶŝĐĂůŽƚŽƌŚŝŶŽůĂƌLJŶŐŽůŽŐLJ͕ŚĞĂĚ͕ĂŶĚŶĞĐŬƐƵƌŐĞƌLJ͘ϮϬϭϯ͖Ϯϳ;ϭϳͿ͗ϵϮϱͲϴ͘